Regencell Bioscience Holdings Ltd
(RGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 06-2007 | |
| Sales | 2,807,900 | 2,893,900 | 2,771,900 | 2,661,200 | 0 |
| Cost of Goods | 1,127,800 | 1,157,100 | 1,097,000 | 1,061,300 | N/A |
| Gross Profit | 1,680,100 | 1,736,800 | 1,674,900 | 1,599,900 | N/A |
| Operating Expenses | 1,465,100 | 1,457,500 | 1,390,500 | 1,278,000 | 0 |
| Operating Income | 215,800 | 279,400 | 284,400 | 322,200 | N/A |
| Interest Expense | 148,100 | 151,000 | 128,400 | 117,200 | 0 |
| Other Income | 58,300 | 28,800 | 30,400 | 396,500 | 0 |
| Pre-tax Income | 126,000 | 157,200 | 186,400 | 601,500 | 0 |
| Income Tax | 48,700 | 61,900 | 74,400 | 241,200 | N/A |
| Net Income Continuous | 77,300 | 95,300 | 112,000 | 360,300 | N/A |
| Minority Interests | -300 | -200 | -200 | -100 | N/A |
| Net Income | $77,600 | $95,500 | $112,200 | $360,400 | $N/A |
| EPS Basic Total Ops | 0.51 | 0.62 | 0.73 | 2.37 | N/A |
| EPS Basic Continuous Ops | 0.50 | 0.62 | 0.73 | 2.37 | N/A |
| EPS Diluted Total Ops | 0.50 | 0.62 | 0.72 | 2.26 | N/A |
| EPS Diluted Continuous Ops | 0.50 | 0.62 | 0.72 | 2.26 | N/A |
| EBITDA(a) | $442,000 | $494,800 | $497,900 | $516,300 | $N/A |